We showed that the expression of CSC markers, such as CD133 and ALDH1A1, and activation of STAT5, were much lower in the tumor of IL-32γ Tg mice as compared with the non-Tg mice (Supplementary Fig. 1A). This evidence concerns the gene STAT5A and neoplasm.